digital health - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,828 +0.66%

DJIA 48,245 +0.70%

Nasdaq 25,056 +0.65%

DAX 23,883 -0.34%

Gold $4,196 +0.16%

Oil $98.04 +1.40%

BTC $71,924 +0.78%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,209 +0.03%

S&P 500 6,828 +0.66%

DJIA 48,245 +0.70%

Nasdaq 25,056 +0.65%

DAX 23,883 -0.34%

Gold $4,196 +0.16%

Oil $98.04 +1.40%

BTC $71,924 +0.78%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,209 +0.03%

digital health

Hims & Hers insider transactions tied to GLP-1 obesity drug strategy with premium treatment kit on dark background

Pharma & Healthcare·Stocks·USA

Hims & Hers insider transactions Warning as GLP-1 bets grow

By Maik Kemper • Mar 17, 2026

Hims & Hers insider transactions tied to GLP-1 obesity drug strategy with premium treatment kit on dark background

Pharma & Healthcare·Stocks·USA

Hims & Hers insider transactions Warning as GLP-1 bets grow

By Maik Kemper • Mar 17, 2026

Are Hims & Hers insider transactions hinting at caution just as the company doubles down on its high-stakes GLP-1 obesity strategy? Maik Kemper Editor-in-Chief Conclusion…